|
| Exchange Disseminated Time 31/10/2016 19:23:00 | With reference to the earlier letter dated October 12, 2016, Neuland Laboratories Ltd has now informed BSE that the meeting scheduled to be held on November 04, 2016, inter alia, would also consider a draft Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited ("the Company"), Neuland Health Sciences Private Limited and Neuland Pharma Research Private Limited, along with the Un-audited financial results of the Company for the quarter ended September 30, 2016.
Also, as informed vide our letter dated October 12, 2016, the Trading Window would remain closed till November 06, 2016 (inclusive) for transactions in the shares of the Company. |
|
|